Literature DB >> 19268667

Mitochondrial involvement in temporal lobe epilepsy.

Alexei P Kudin1, Gábor Zsurka, Christian E Elger, Wolfram S Kunz.   

Abstract

Mitochondrial dysfunction has been identified as a potential cause of epileptic seizures and therapy-resistant forms of severe epilepsy. Thus, a broad variety of mutation in mitochondrial DNA or nuclear genes leading to the impairment of mitochondrial respiratory chain or of mitochondrial ATP synthesis has been associated with epileptic phenotypes. Additionally, with a variety of different methods impaired mitochondrial function has been reported for the seizure focus of patients with temporal lobe epilepsy and Ammon's horn sclerosis and of animal models of temporal lobe epilepsy. Since mitochondrial oxidative phosphorylation provides the major source of ATP in neurons and mitochondria participate in cellular Ca(2+) homeostasis, their dysfunction strongly affects neuronal excitability and synaptic transmission, which is proposed to be highly relevant for seizure generation. Additionally, mitochondrial dysfunction is known to trigger neuronal cell death, which is a prominent feature of therapy-resistant temporal lobe epilepsy. Therefore, mitochondria have to be considered as promising targets for neuroprotective strategies in epilepsy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19268667     DOI: 10.1016/j.expneurol.2009.02.014

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  29 in total

Review 1.  Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection.

Authors:  Gregor Zündorf; Georg Reiser
Journal:  Antioxid Redox Signal       Date:  2010-10-06       Impact factor: 8.401

Review 2.  Astrocytes and Glutamine Synthetase in Epileptogenesis.

Authors:  Tore Eid; Tih-Shih W Lee; Peter Patrylo; Hitten P Zaveri
Journal:  J Neurosci Res       Date:  2018-07-18       Impact factor: 4.164

Review 3.  Targeting BK (big potassium) channels in epilepsy.

Authors:  Prosper N'Gouemo
Journal:  Expert Opin Ther Targets       Date:  2011-09-19       Impact factor: 6.902

4.  Anticonvulsant and antioxidant actions of trimetazidine in pentylenetetrazole-induced kindling model in mice.

Authors:  Seema Jain; Nidhi Bharal; Sonam Khurana; Pramod Kumari Mediratta; Krishna Kishore Sharma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-02-12       Impact factor: 3.000

Review 5.  The potential role of mitochondrial dysfunction in seizure-associated cell death in the hippocampus and epileptogenesis.

Authors:  Shang-Der Chen; Alice Y W Chang; Yao-Chung Chuang
Journal:  J Bioenerg Biomembr       Date:  2010-12       Impact factor: 2.945

Review 6.  Mitochondrial matters of the brain: mitochondrial dysfunction and oxidative status in epilepsy.

Authors:  Sue-Joan Chang; Bu-Chin Yu
Journal:  J Bioenerg Biomembr       Date:  2010-12       Impact factor: 2.945

7.  Dynamin-Related Protein 1 Promotes Mitochondrial Fission and Contributes to The Hippocampal Neuronal Cell Death Following Experimental Status Epilepticus.

Authors:  Shang-Der Chen; Yen-Yi Zhen; Jui-Wei Lin; Tsu-Kung Lin; Chin-Wei Huang; Chia-Wei Liou; Samuel H H Chan; Yao-Chung Chuang
Journal:  CNS Neurosci Ther       Date:  2016-08-31       Impact factor: 5.243

Review 8.  Diseases associated with defective responses to DNA damage.

Authors:  Mark O'Driscoll
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-12-01       Impact factor: 10.005

Review 9.  A Molecular Approach to Epilepsy Management: from Current Therapeutic Methods to Preconditioning Efforts.

Authors:  Elham Amini; Mohsen Rezaei; Norlinah Mohamed Ibrahim; Mojtaba Golpich; Rasoul Ghasemi; Zahurin Mohamed; Azman Ali Raymond; Leila Dargahi; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2014-09-09       Impact factor: 5.590

10.  Increased oxidative stress and impaired antioxidant response in Lafora disease.

Authors:  Carlos Romá-Mateo; Carmen Aguado; José Luis García-Giménez; José Santiago Ibáñez-Cabellos; Marta Seco-Cervera; Federico V Pallardó; Erwin Knecht; Pascual Sanz
Journal:  Mol Neurobiol       Date:  2014-05-17       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.